BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023

  Oxford Biomedica plc announces interim results for the six months ended 30 June 2023.

  September 20, 2023

   · 

  97 min read
• Biotech Beach

  Capsida Biotherapeutics to Present at Jefferies Cell & Genetic Medicine Summit and the 2023 Cell & Gene Meeting on the Mesa

  Capsida Biotherapeutics (“Capsida”) today announced that Peter Anastasiou, Chief Executive Officer, will present a corporate update at the following upcoming investor and industry conferences.

  September 20, 2023

   · 

  1 min read
• Oxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed acquisition by Oxford Biomedica of ABL Europe from Institut Mérieux as part of pure-play CDMO transformation

  Oxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed acquisition by Oxford Biomedica of ABL Europe from Institut Mérieux as part of pure-play CDMO transformation

  September 20, 2023

   · 

  10 min read
• Business

  Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List

  Science 37 Holdings, Inc., the clinical research industry-leading Metasite™, announced that its Chief Delivery Officer, Darcy Forman, has been honored with a coveted spot on the prestigious PharmaVoice 100 list.

  September 20, 2023

   · 

  6 min read
• Biotech Bay

  Corsair Pharma Announces $23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension

  Corsair Pharma, Inc. today announced the closing of its $23M Series B financing led by New Rhein Healthcare Investors.

  September 20, 2023

   · 

  3 min read
• Drug Development

  Vir Biotechnology Announces First Participant Dosed in New Phase 1 Trial Evaluating VIR-1388, an Investigational T Cell Vaccine for the Prevention of HIV

  Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the first participant has been dosed in a Phase 1 trial evaluating the safety, reactogenicity and immunogenicity of VIR-1388, an investigational novel T cell vaccine for the prevention of human immunodeficiency virus (HIV).

  September 20, 2023

   · 

  6 min read
• Business

  PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose

  PROCEPT BioRobotics® Corporation, a surgical robotics company focused on developing transformative solutions in urology, proudly announces the grand opening of its state-of-the-art global corporate headquarters in San Jose, California.

  September 20, 2023

   · 

  2 min read
• Genetown

  Solid Biosciences to Participate at Upcoming Investor Conferences - September 20, 2023

  Solid Biosciences Inc. today announced that Bo Cumbo, President and Chief Executive Officer, will participate in the following three upcoming investor conferences.

  September 20, 2023

   · 

  1 min read
• Pharm Country

  IN8bio to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference

  IN8bio, Inc. today announced William Ho, CEO and co-founder, will participate in a panel presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2023, at 8:35 a.m. ET.

  September 20, 2023

   · 

  1 min read
• Pharm Country

  Lisata Therapeutics Announces Participation in InfoSec World 2023

  Lisata Therapeutics, Inc. announces that Gregory Berkin, Chief Information Officer at Lisata, will participate at InfoSec World 2023 being held September 25-27, 2023, in Lake Buena Vista, Florida.

  September 20, 2023

   · 

  1 min read